To determine which immune cell subtypes drive the anti-tumor activity and toxicity of αmPD1-IL-2x or mAWT020, CD8 T cell or NK cell depletion was performed in MC38 tumor-bearing C57/BL6 mice. This evidence concerns the gene CD8A and neoplasm.